Ledger.Open graph →
SEC Form D · filed June 2, 2023

SURGE Therapeutics, Inc

Offering
$50.0M
Sold
$32.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Gary S. Goldberg · Cambridge, MADirectorMichael S. Goldberg · Cambridge, MAExec · DirectorJason S. Coloma · Cambridge, MADirectorAntonio S. Gualberto · Cambridge, MAExecKouki S. Harasaki · Cambridge, MADirectorChuck S. Carignan · Cambridge, MAExecAli S. Farahanchi · Cambridge, MADirectorGary S. Goldberg · Cambridge, MADirectorMichael S. Goldberg · Cambridge, MAExec · DirectorJason S. Coloma · Cambridge, MADirectorChuck S. Carignan · Cambridge, MAExecAntonio S. Gualberto · Cambridge, MAExecKouki S. Harasaki · Cambridge, MADirectorAli S. Farahanchi · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗